Evidence map›Paper›PMID 34812008›Full record

ArticleSe pu = Chinese journal of chromatography2021

[Determination of the enantiomers of salmeterol xinafoate in salmeterol fluticasone powder inhalant by chiral nonaqueous capillary electrophoresis].

Xu Zhang, Miaoxue Dong, Yin Xu, Lijuan Wang, Xiaoqiang Qiao

Open access · hybridAbstract read
In one paragraph

Article in Se pu = Chinese journal of chromatography, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Xu ZhangKey Laboratory of Pharmaceutical Quality Control of Hebei Province, Institute of Life Science and Green Development, College of Pharmaceutical Sciences, Hebei University, Baoding 071002, China.
Miaoxue DongKey Laboratory of Pharmaceutical Quality Control of Hebei Province, Institute of Life Science and Green Development, College of Pharmaceutical Sciences, Hebei University, Baoding 071002, China.
Yin XuTianjin Alta Scientific Co., Ltd., Tianjin 300457, China.
Lijuan WangKey Laboratory of Pharmaceutical Quality Control of Hebei Province, Institute of Life Science and Green Development, College of Pharmaceutical Sciences, Hebei University, Baoding 071002, China.
Xiaoqiang QiaoKey Laboratory of Pharmaceutical Quality Control of Hebei Province, Institute of Life Science and Green Development, College of Pharmaceutical Sciences, Hebei University, Baoding 071002, China.
Hebei University · CNTianjin Academy of Fine Arts · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salmeterol xinafoate (SalX) is one of the ideal drugs used for the treatment of nocturnal asthma attacks and daily maintenance. The molecular structure of SalX contains a chiral carbon atom, and thus, SalX has two enantiomers, viz. (

Indexed as

Electrophoresis, CapillaryFluticasonePowdersReproducibility of ResultsSalmeterol XinafoateStereoisomerismFluticasonePowdersSalmeterol XinafoateenantiomerL(+)-tartaric acid-boric acid complexnonaqueous capillary electrophoresis (NACE)salmeterol fluticasone powder inhalant

Identifiers

PMID34812008
PMCPMC9404210
OpenAlexW3216271580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.